Literature DB >> 8236018

Congenital hemangiopericytoma: an unusual vascular neoplasm of infancy.

P V Bailey1, T R Weber, T F Tracy, D M O'Connor, C Sotelo-Avila.   

Abstract

BACKGROUND: Hemangiopericytoma is an uncommon tumor of infants, which originates from the vascular pericytes. Although generally considered to benign, metastases can occur.
METHODS: Five cases of congenital hemangiopericytoma were seen in infants; all were found in females. The mean age at diagnosis was 7 weeks (range, birth to 10 weeks). The lesions were located in the neck, the parotid, the axilla, and the retroperitoneum. One neck lesion was detected prenatally by ultrasonography. Each lesion was resected. The diagnosis of congenital hemangiopericytoma was established only after histologic examination.
RESULTS: No evidence of recurrence has been found in four of the children. However, intrathoracic and intracranial metastases developed in one child with a neck lesion 28 months after the original resection, and the child was treated with chemotherapy, but she died of progressive disease.
CONCLUSIONS: We advocate the consideration of congenital hemangiopericytoma in the newborn infant with a vascular mass. Because congenital hemangiopericytoma is unresponsive to steroid therapy, unlike other vascular malformations, resection is the treatment of choice. Long-term postoperative follow-up is essential for the early detection of metastases.

Entities:  

Mesh:

Year:  1993        PMID: 8236018

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  3 in total

1.  Progressive proptosis in a neonate.

Authors:  D A O'Driscoll; M O'Neill
Journal:  Postgrad Med J       Date:  1998-09       Impact factor: 2.401

2.  Case report: neonatal giant forehead hemangiopericytoma with a 5-year follow-up.

Authors:  AiJun Peng; LiBing Zhang; Hai Zhao; LiangXue Zhou
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

3.  The impact of low-dose glucocorticoids on disease activity, bone mineral density, fragility fractures, and 10-year probability of fractures in patients with rheumatoid arthritis.

Authors:  Tien-Tsai Cheng; Han-Ming Lai; Shan-Fu Yu; Wen-Chan Chiu; Chung-Yuan Hsu; Jia-Feng Chen; Ying-Chou Chen
Journal:  J Investig Med       Date:  2018-06-10       Impact factor: 2.895

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.